感染新型冠状病毒肺炎的人类免疫缺陷病毒患者的临床特征与预后
Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.
作者信息
Gervasoni Cristina, Meraviglia Paola, Riva Agostino, Giacomelli Andrea, Oreni Letizia, Minisci Davide, Atzori Chiara, Ridolfo Annalisa, Cattaneo Dario
机构信息
Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
出版信息
Clin Infect Dis. 2020 Nov 19;71(16):2276-2278. doi: 10.1093/cid/ciaa579.
Abstract
Little is known about the clinical outcomes of patients with human immunodeficiency virus infected with SARS-CoV-2. We describe 47 patients referred to our hospital between 21 February and 16 April 2020 with proven/probable COVID-19, 45 (96%) of whom fully recovered and 2 who died.
摘要
关于感染了严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的人类免疫缺陷病毒患者的临床结局，目前所知甚少。我们描述了2020年2月21日至4月16日期间转诊至我院的47例确诊/疑似新型冠状病毒肺炎（COVID-19）患者，其中45例（96%）完全康复，2例死亡。
相似文献
1
Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.感染新型冠状病毒肺炎的人类免疫缺陷病毒患者的临床特征与预后
Clin Infect Dis. 2020 Nov 19;71(16):2276-2278. doi: 10.1093/cid/ciaa579.
2
Factors associated with hospital admission for COVID-19 in HIV patients.与 HIV 患者因 COVID-19 住院相关的因素。
AIDS. 2020 Nov 1;34(13):1983-1985. doi: 10.1097/QAD.0000000000002663.
3
Risk Factors for Hospitalization in People With HIV and COVID-19.感染HIV和COVID-19患者的住院风险因素
J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):e22. doi: 10.1097/QAI.0000000000002780.
4
Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2.两面作战：感染新冠病毒的艾滋病毒感染者中的药物相互作用
Eur J Hosp Pharm. 2021 Jan;28(1):e3. doi: 10.1136/ejhpharm-2020-002390. Epub 2020 Jun 10.
5
Unusual association of COVID-19, pulmonary tuberculosis and human immunodeficiency virus, having progressed favorably under treatment with chloroquine and rifampin.新型冠状病毒肺炎、肺结核和人类免疫缺陷病毒的罕见关联，在氯喹和利福平治疗下病情进展良好。
Pan Afr Med J. 2020 Jul 13;35(Suppl 2):110. doi: 10.11604/pamj.supp.2020.35.2.24952. eCollection 2020.
6
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性（COVID-Preg）：一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
7
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.COVID-19 患者中 SARS-CoV-2 病毒持续排出与阿比多尔治疗开始延迟和就诊时间推迟有关：一项回顾性队列研究。
Curr Med Sci. 2021 Dec;41(6):1096-1104. doi: 10.1007/s11596-021-2434-y. Epub 2021 Sep 13.
8
Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living With Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study.武汉市人类免疫缺陷病毒感染者中 2019 年冠状病毒病（COVID-19）病例的流行病学、病毒学和血清学特征：一项基于人群的队列研究。
Clin Infect Dis. 2021 Oct 5;73(7):e2086-e2094. doi: 10.1093/cid/ciaa1186.
9
The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe.HIV 阳性患者中轻症/无症状和中重度 COVID-19 患者的特征——来自中东欧的报告。
Int J Infect Dis. 2021 Mar;104:293-296. doi: 10.1016/j.ijid.2020.12.026. Epub 2020 Dec 14.
10
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.与 SARS-CoV-2 感染住院非重症患者病毒持续排出相关因素及洛匹那韦/利托那韦治疗的影响。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.
引用本文的文献
1
Tuberculosis Trends in the Post-COVID-19 Era: Is It Going to be a Global Concern?新冠疫情后时代的结核病趋势：它会成为全球关注的问题吗？
Health Sci Rep. 2025 May 21;8(5):e70792. doi: 10.1002/hsr2.70792. eCollection 2025 May.
2
A cross-section study of the relationship between lifestyles and severity of COVID-19 symptoms in people living with HIV.一项关于HIV感染者生活方式与COVID-19症状严重程度之间关系的横断面研究。
Sci Rep. 2025 May 20;15(1):17464. doi: 10.1038/s41598-025-99528-1.
3
Factors affecting poor prognosis of COVID-19 in people living with human immunodeficiency virus: A systematic review and meta-analysis of co-infection.影响人类免疫缺陷病毒感染者中COVID-19预后不良的因素：合并感染的系统评价和荟萃分析
Int J Health Sci (Qassim). 2025 Jan-Feb;19(1):49-55.
4
SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the Literature.SARS-CoV-2 变异株和特殊人群的临床结局：文献的范围综述。
Viruses. 2024 Jul 30;16(8):1222. doi: 10.3390/v16081222.
5
Clinical characteristics and variables associated with COVID-19 morbidity and mortality in Luanda, Angola, in the first year of the pandemic.安哥拉罗安达市在大流行第一年与 COVID-19 发病率和死亡率相关的临床特征和变量。
Afr Health Sci. 2023 Dec;23(4):51-63. doi: 10.4314/ahs.v23i4.9.
6
Assessing COVID-19 Vulnerability Among HIV-positive Men Who Have Sex With Men in Korea: The Role of Vaccination and Sexual Behaviors.评估韩国男男性行为者中艾滋病毒阳性者感染新冠病毒的易感性：疫苗接种和性行为的作用
J Prev Med Public Health. 2024 Jul;57(4):370-378. doi: 10.3961/jpmph.24.196. Epub 2024 Jun 24.
7
Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.HIV 感染者感染 SARS-CoV-2 的临床结局和免疫反应。
Exp Biol Med (Maywood). 2024 Apr 2;249:10059. doi: 10.3389/ebm.2024.10059. eCollection 2024.
8
[Description of 12 HIV-positive patients who have had the COVID-19 in our area].[关于我们地区12例感染新冠病毒的HIV阳性患者的描述]
Enferm Infecc Microbiol Clin. 2021 Apr;39(4):208-210. doi: 10.1016/j.eimc.2020.06.014. Epub 2020 Jul 11.
9
Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.SIV 感染恒河猴中针对 SARS-CoV-2 二价 mRNA 疫苗的中和抗体反应：两剂接种增强对 XBB 亚变种的免疫力。
J Med Virol. 2024 Mar;96(3):e29520. doi: 10.1002/jmv.29520.
10
Mortality Among Persons With HIV in the United States During the COVID-19 Pandemic: A Population-Level Analysis.美国在 COVID-19 大流行期间感染艾滋病毒人群的死亡率：基于人群水平的分析。
J Acquir Immune Defic Syndr. 2024 Feb 1;95(2):126-132. doi: 10.1097/QAI.0000000000003347.
Zotero 插件